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Enterococci are Gram-positive bacteria that are found in plants, soil and as commensals
of the gastrointestinal tract of humans, mammals, and insects. Despite their commensal
nature, they have also become globally important nosocomial pathogens. Within the
genus Enterococcus, Enterococcus faecium, and Enterococcus faecalis are clinically
most relevant. In this review, we will discuss how E. faecium and E. faecalis have
evolved to become a globally disseminated nosocomial pathogen. E. faecium has
a defined sub-population that is associated with hospitalized patients and is rarely
encountered in community settings. These hospital-associated clones are characterized
by the acquisition of adaptive genetic elements, including genes involved in metabolism,
biofilm formation, and antibiotic resistance. In contrast to E. faecium, clones of E. faecalis
isolated from hospitalized patients, including strains causing clinical infections, are not
exclusively found in hospitals but are also present in healthy individuals and animals.
This observation suggests that the division between commensals and hospital-adapted
lineages is less clear for E. faecalis than for E. faecium. In addition, genes that
are reported to be associated with virulence of E. faecalis are often not unique to
clinical isolates, but are also found in strains that originate from commensal niches.
As a reflection of more ancient association of E. faecalis with different hosts, these
determinants Thus, they may not represent genuine virulence genes but may act as
host-adaptive functions that are useful in a variety of intestinal environments. The scope
of the review is to summarize recent trends in the emergence of antibiotic resistance
and explore recent developments in the molecular epidemiology, population structure
and mechanisms of adaptation of E. faecium and E. faecalis.
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INTRODUCTION
Enterococci are low-GC Gram-positive ovococci that can form pairs and chains
of diverse lengths. Bacteria from the genus Enterococcus are facultative anaerobic
and grow optimally at 35◦C, but can tolerate temperatures ranging from 10◦C to
45◦C (Byappanahalli et al., 2012). The genus comprises 54 species (Parte, 2014),
which are ubiquitously present in nature but the gastrointestinal tract (GIT)
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of animals, including mammals, reptiles, birds (Mundt, 1963a)
and insects (Martin and Mundt, 1972), is thought to be the largest
reservoir of enterococci (Gilmore et al., 2013).
In humans, enterococci are common commensals of the GIT.
In addition, enterococci have become ever more prominent
as a causative agent of nosocomial infections since the 1970s
(Arias and Murray, 2012). Two species, Enterococcus faecalis
and Enterococcus faecium, cause the vast majority of hospital-
acquired enterococcal infections in humans (Agudelo Higuita
and Huycke, 2014). Of these two, E. faecium has rapidly
acquired resistance to several classes of antibiotics. First, in
the 1970s and 1980s, E. faecium gained high-level resistance
to ampicillin (Grayson et al., 1991; Galloway-Peña et al., 2009)
and since the 1980s it acquired resistance to aminoglycosides,
fluoroquinolones, and glycopeptides, particularly vancomycin
(Leclercq et al., 1988; Uttley et al., 1988; National Nosocomial
Infections Surveillance System, 2004). E. faecalis has also acquired
resistance to aminoglycosides, but resistance to ampicillin and
vancomycin is much rarer than in E. faecium (Edelsberg et al.,
2014). Worryingly, resistance to antibiotics that are used to
treat vancomycin resistant enterococci (VRE), like linezolid,
tigecycline, and daptomycin, has already been reported (Aksoy
and Unal, 2008; Montero et al., 2008; Scheetz et al., 2008; Niebel
et al., 2015).
The intrinsic resistance of enterococci to some antibiotics,
including aminoglycosides, and the ability to acquire and
disseminate antibiotic resistance determinants, like those
involved in vancomycin resistance, only partly explain the
recent emergence of these organisms as nosocomial pathogens.
In addition, the plasticity of the enterococcal genomes allow
enterococci to rapidly respond and adapt to selective constraints
by acquiring genetic determinants that increase their ability
to colonize or infect the host (Hendrickx et al., 2009; Palmer
et al., 2012; Lebreton et al., 2013; Van Tyne and Gilmore, 2014).
Other host or environmental factors, most notably exposure
to antimicrobial agents, may favor an increase in colonization
density of enterococci in the GIT of hospitalized patients
(Donskey et al., 2000; Ubeda et al., 2010; Ruiz-Garbajosa et al.,
2012). Antibiotic therapy that leads to the depletion of Gram-
negatives, can reduce production of the antimicrobial peptide
REGIIIγ by Paneth cells, and this may promote the outgrowth of
VRE (Brandl et al., 2008).
Patients undergoing transplants or with underlying diseases,
such as diabetes or renal failure, and patients with long-term
catheter usage, are at higher risk of developing infections
caused by multi-drug resistant (MDR) enterococci (Arias
and Murray, 2012). High-density colonization of the patient
GIT facilitates the transmission of MDR enterococci among
hospital ward through fecal contamination (Arias and Murray,
2012). Therefore epidemiological surveillance and outbreak
investigations, together with infection control polices and
interventions, such as the use of protective barriers and proper
disinfection, are key for infection control of these organisms
in the nosocomial environment (Sydnor and Perl, 2011). High-
level enterococcal GIT colonization can also lead to urinary
tract infections (UTI) (De Vecchi et al., 2013; Neelakanta
et al., 2015), which may progress to bloodstream infections or
endocarditis (Patterson et al., 1995; Fernández-Guerrero et al.,
2002). Enterococci from high-density intestinal populations may
also directly translocate from the GIT into the bloodstream
(Kamboj et al., 2014).
Enterococci have become one of the most common causes
of health care-associated infections with E. faecalis causing
approximately 60% of infections and E. faecium the remainder
(de Kraker et al., 2013; Sievert et al., 2013). This review will
focus on E. faecalis and E. faecium as both species have emerged
as important nosocomial pathogens over the last 30 years
and represent a major hub for the dissemination of antibiotic
resistance genes.
EMERGENCE OF ANTIBIOTIC
RESISTANCE IN ENTEROCOCCI
Enterococcus faecalis and E. faecium exhibit intrinsic resistance
to a broad range of antibiotics. Below we briefly describe the
mechanisms that cause resistance to the classes of antibiotics that
are currently used in the treatment of enterococcal infections.
Compared to other low-GC Gram-positive cocci, enterococci
exhibit decreased susceptibility to β-lactam antibiotics.
The β-lactams act through the inactivation of penicillin-
binding proteins (PBPs), thereby interfering with synthesis of
peptidoglycan. All enterococci display decreased susceptibility
to β-lactam antibiotics due to the expression of PBPs with an
intrinsic low affinity for this class of antibiotics. Resistance to
β-lactams, most notably to ampicillin, is currently far more
widespread in E. faecium than in E. faecalis (Cattoir and Giard,
2014). The most important determinants for β-lactam resistance
in E. faecium are mutations in the genes encoding the PBP5
(Zorzi et al., 1996; Rice et al., 2001; Zhang et al., 2012). There
are clear indications that E. faecium progressed toward high-
level ampicillin resistance in the 1970s and 1980s through the
acquisition of specific mutations in the pbp5 gene (Grayson et al.,
1991; Galloway-Peña et al., 2009, 2011). It is of importance to
note that these chromosomally encoded PBPs can be transferable
(Dahl et al., 2000; Hanrahan et al., 2000; Rice et al., 2005), which
indicates that dissemination of high-level ampicillin resistance
can be the result of both clonal spread of strains with mutated
pbp5 genes and horizontal gene transfer. In addition to mutations
in pbp5, production of β-lactamase has been described in both
E. faecalis and E. faecium (Tomayko et al., 1996; Sarti et al., 2012).
In general, the expression level of beta-lactamase in these species
is low and impact on ampicillin susceptibility marginal.
Another group of antibiotics to which E. faecium and
E. faecalis exhibit moderate intrinsic and high-level acquired
resistance are the aminoglycosides. In E. faecalis, intrinsic
resistance is thought to be caused by the inability of the antibiotic
to enter the cytoplasm and inhibit ribosomal protein synthesis
(Aslangul et al., 2006). In E. faecium, two chromosomally
encoded genes, a 6′-N-aminoglycoside acetyltransferase (aac(6′)-
Ii) (Costa et al., 1993) and an rRNA methyltransferase
(efmM) (Galimand et al., 2011), have been associated with
intrinsic resistance to tobramycin and kanamycin. In addition
to intrinsic resistance to aminoglycosides, the therapeutic
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success of these antibiotics is critically compromised by high-
level resistance, due to the gain of aminoglycoside modifying
enzymes, such as phosphotransferases, acetyltransferases, and
nucleotidyltransferases by E. faecium and E. faecalis (Chow, 2000;
Miller et al., 2014).
The assessment of enterococci, particularly E. faecium, as
important agents of MDR nosocomial infections was definitively
established when they acquired resistance to vancomycin.
While vancomycin-resistant enterococci were virtually non-
existent in hospitals in the USA before 1990, nowadays
87% of E. faecium strains from nosocomial infections are
vancomycin-resistant, while this is only 14% for E. faecalis
(Edelsberg et al., 2014). Vancomycin is a glycopeptide antibiotic,
which prevents cross-linking of peptidoglycan by binding to
the D-alanine-D-alanine (D-Ala-D-Ala) moiety of the peptide
chains that crosslink peptidoglycans. The mechanisms by
which enterococci become resistant to vancomycin have been
extensively reviewed elsewhere (Courvalin, 2006). In short,
enterococci become resistant to vancomycin when the terminal
amino acids of peptidoglycan precursors are altered from D-Ala-
D-Ala to D-Ala-D-lactate (D-Ala-D-Lac) or to D-Ala-D-Serine
(D-Ala-D-Ser), leading to high-level and low-level resistance to
vancomycin, respectively. Nine gene clusters are currently known
to be involved in vancomycin resistance in enterococci. These
vancomycin resistance gene clusters are vanA, vanB, vanD, and
vanM, causing vancomycin resistance through the formation of
D-Ala-D-Lac, and vanC, vanE, vanG, vanL, and vanN which
catalyze the formation of D-Ala-D-Ser (Courvalin, 2006; Boyd
et al., 2008; Xu et al., 2010; Lebreton et al., 2011). The most
frequently found, and thus clinically most relevant, vancomycin
resistance determinants are vanA and vanB, which are both part
of larger gene clusters, which encode a two-component regulatory
system and enzymes involved in the recycling of D-Ala-D-Ala
peptidoglycan precursors to D-Ala-D-Lac. Both vanA and vanB
are located on transposons that contribute to the dissemination
of vancomycin resistance among enterococci (Courvalin, 2006).
Recently, vanM was found to be the most important vancomycin-
resistance determinant among different E. faecium lineages in
hospitals in Shanghai, China (Chen et al., 2015). Differences in
the sequence diversity and prevalence of each van operon could
be due to the different ecological origins of the van clusters. While
vanA seems to have originated from soil organisms, vanB, vanG,
and vanD have been reported in gut commensal microbiota
(Guardabassi et al., 2005; Domingo et al., 2007; Howden et al.,
2013).
While vancomycin resistance emerged and spread in
USA hospitals in the 1990s, carriage of vancomycin-resistant
E. faecium (VREF) was rare among hospitalized patients in
Europe. In contrast, VRE carriage among farm animals, and, to a
lesser extent, in healthy humans was higher in Europe than in the
USA (Klare et al., 1995; Devriese et al., 1996; Stobberingh et al.,
1999). The widespread occurrence of VRE among farm animals
was linked to the use of the vancomycin-analog avoparcin as a
growth promoter in Europe (Bager et al., 1997). The presence
of indistinguishable vancomycin resistance transposons in both
animal and human reservoirs provided the first indication that
animal-derived enterococci could be a reservoir of antibiotic
resistance genes that could be transmitted to humans (Arthur
et al., 1993; Jensen et al., 1998; Woodford et al., 1998; Willems
et al., 1999). After the ban on the use of avoparcin in 1997, the
prevalence of VRE in animal husbandry declined in Europe
(Klare et al., 1999; van den Bogaard et al., 2000; Aarestrup et al.,
2001). In several European countries, the prevalence of VRE
among hospitalized patients increased in the 21st century, but
is still lower than the endemic levels reported in US hospitals
(Bourdon et al., 2011; Gastmeier et al., 2014; Pinholt et al., 2015;
Simner et al., 2015). Levels of VRE among hospitalized patients
are also high in Australia, with 37% of E. faecium bacteremia
isolates exhibiting resistance to vancomycin. Interestingly,
vancomycin resistance in Australian E. faecium isolates is almost
exclusively caused by vanB-type transposons, while vanA is the
major vancomycin-resistance determinant in Europe and the
USA (Coombs et al., 2014).
Due to the emergence and rapid spread of VRE, the antibiotics
linezolid, daptomycin and tigecycline are increasingly used for
the treatment of VRE infections.
Linezolid, the first oxazolidinone antibiotic, was introduced
for clinical use in the USA in 2000. It acts on the ribosome
by binding to a universally conserved site on 23S rRNA of the
large 50S subunit of the ribosome (Colca et al., 2003), thereby
inhibiting elongation of the polypeptide chain. The currently
described linezolid resistance mechanisms alter the peptidyl
transferase center of 23S rRNA, by a mutation in the 23S rRNA
gene, with the G2576T mutation being most prominent (Jones
et al., 2008), mutations in the genes encoding ribosomal proteins
L3 and L4 (Chen et al., 2013) or methylation of the adenine
at position 2503, which is catalyzed by the methyltransferase
Cfr. The cfr gene is encoded on various conjugative and non-
conjugative plasmids in enterococci (Diaz et al., 2012; Shen
et al., 2013). Recently, the oxazolidinone resistance gene optrA
has been identified in E. faecalis and E. faecium isolates of
human and animal origin (Cai et al., 2015; Wang et al.,
2015). This gene codes for an ATP-binding cassette transporter,
which contributes to reduced susceptibility for oxazolidinones
(linezolid and tedizolid) and phenicols (chloramphenicol and
florfenicol). The optrA gene was associated with a conjugative
plasmid (Wang et al., 2015). Nevertheless, linezolid resistance is
still rare. In a study using data from 19 US hospitals in the period
2007–2010, linezolid resistance was reported in 1.1 and 1.8% of
E. faecium and E. faecalis isolates, respectively (Edelsberg et al.,
2014).
Daptomycin is a lipopeptide antibiotic that targets the cell
membrane through interactions with phospholipids (Humphries
et al., 2013). The genetic basis for resistance in E. faecalis and
E. faecium was first studied through genome sequencing of pairs
of strains that developed resistance in vitro or in vivo (Arias
et al., 2011; Palmer et al., 2011; Tran et al., 2013a). Additional
genetic and biochemical work has established the role of the
three-component regulatory system LiaFSR in contributing to
daptomycin resistance in enterococci. The LiaFSR system is
conserved in low-GC Gram-positive bacteria and governs the cell
envelope stress response (Jordan et al., 2006). Mutations in the
liaF gene of E. faecalis lead to a redistribution of cardiolipin-rich
microdomains from the division septum to other regions of the
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cytoplasmic membrane, which affects the antimicrobial activity
of daptomycin. In addition, other mutations in phospholipid
biosynthesis genes, most notably in the cardiolipin synthase gene
cls, are required for full expression of daptomycin resistance in
E. faecalis (Davlieva et al., 2013; Tran et al., 2013b). Similar
mechanisms have been associated with daptomycin resistance
in E. faecium (Munita et al., 2012, 2014; Davlieva et al., 2013).
Notably, emergence of daptomycin resistance in E. faecium
during daptomycin therapy is not always linked to mutations in
liaFSR and mutations in cls may already be sufficient (Kelesidis
et al., 2013; Lellek et al., 2015). Daptomycin resistance is
infrequent, but more common in E. faecium than in E. faecalis.
A worldwide study in isolates from hospitalized patients over
the period 2005–2012 showed levels of daptomycin resistance
of 0.18% for E. faecium and 0.02% for E. faecalis (Sader et al.,
2014). However, in certain settings daptomycin resistance may
be considerably more frequent, as illustrated by a study including
4,274 E. faecium and 7,007 E. faecalis isolates from 19 US
hospitals, which found daptomycin resistance among 3.9 and
0.2% of E. faecium and E. faecalis isolates, respectively (Edelsberg
et al., 2014). Similar levels of daptomycin resistance in E. faecium
were recently reported for a German hospital (Lübbert et al.,
2015).
Tigecycline is a semisynthetic derivative of the broad-
spectrum tetracycline antibiotic minocycline, which acts on the
ribosome by inhibiting its association with aminoacyl-tRNAs.
The emergence of resistance during tigecycline therapy was first
observed in E. faecalis (Werner et al., 2008; Cordina et al., 2012)
and has recently been described in E. faecium (Niebel et al.,
2015). In enterococci, resistance to tigecycline can be mediated
through upregulation of tetracycline resistance determinants
tetL (encoding an eﬄux pump) and tetM (providing ribosomal
protection) (Fiedler et al., 2015) and mutations in the ribosomal
protein rpsJ (Beabout et al., 2015; Cattoir et al., 2015; Niebel
et al., 2015). Tigecycline resistance among E. faecium and
E. faecalis is rare at 0.3% for both species (Hoban et al.,
2015) and the antibiotic can still be used successfully to treat
bacteremias caused by MDR enterococci, especially when it is
used in combination with daptomycin (Polidori et al., 2011). The
recovery of enterococcal isolates with decreased susceptibility to
tigecycline in samples of animal origin is of concern, as extensive
use with tetracyclines in the veterinary setting could select for
tigecycline tolerant strains (Freitas et al., 2011).
In addition to the antibiotics described above, the antibiotics
tedizolid, telavancin, dalbavancin, and oritavancin have recently
been approved by the Food and Drug Administration in the USA
for the treatment of skin infections by Gram-positive bacteria
(Crotty et al., 2016). Tedizolid is an oxazolidinone antibiotic
that has improved in vitro activity compared to linezolid.
Enterococcal strains that have acquired linezolid resistance due
to the acquisition of the cfr gene or the G2576T mutation
in the 23S rRNA gene, may still have relatively low MICs
(≤4 µg/ml) for tedizolid (Barber et al., 2016; Silva-Del Toro
et al., 2016). Telavancin, dalbavancin and oritavancin are semi-
synthetic glycopeptides antibiotics that, similar to vancomycin,
affect peptidoglycan stability by binding to the D-Ala-D-Ala
moiety of the peptide chains that crosslink peptidoglycan chains.
Interestingly, oritavancin is also active against vanA- and vanB-
type vancomycin-resistant enterococci, while telavancin and
dalbavancin have limited activity against enterococci carrying
the vanA-type vancomycin resistance transposon but are active
against enterococci with vanB-type vancomycin resistance (Jones
et al., 2013; Karlowsky et al., 2015). Tedizolid, telavancin,
dalbavancin, and oritavancin may be useful as alternatives
to linezolid and vancomycin, but they do not have radically
different modes of action and they may therefore suffer from the
same resistance mechanisms that are threatening the efficacy of
linezolid and vancomycin. Therefore, antibiotics that target other
structures in the enterococcal cell, including teixobactin (Ling
et al., 2015) and the acyldepsipeptides (Brötz-Oesterhelt et al.,
2005), hold considerable promise as novel compounds for the
treatment of infections with MDR enterococci.
MOLECULAR EPIDEMIOLOGY AND
POPULATION STRUCTURE OF
E. faecium AND E. faecalis
E. faecium
As a consequence of the global rise of VREF, a large number
of molecular epidemiological studies have been performed to
obtain insights into the dissemination of VREF clones in
and between hospitals, in farm animals and healthy humans.
However, methods like pulse-field gel electrophoresis (PFGE),
soon proved to be insufficiently reproducible to study genetic
relatedness of isolates (Morrison et al., 1999).
A first insight into the existence of particular ecotypes
in E. faecium, was obtained by using amplified fragment
polymorphism (AFLP) to infer the genetic relatedness of strains
from diverse hosts and environments (Willems et al., 2000). This
study revealed that strains from hospitalized patients grouped in
a specific sub-population that was distinct from groups of strains
that were isolated from humans in the community and farm
animals.
The use of AFLP for global studies showed the limitations of
this technique for comparisons of data obtained from different
laboratories. Therefore an alternative method, termed multi locus
sequence typing (MSLT), was used in follow-up studies. In
MLST, allelic profiles are based on the sequences of fragments
of a number of housekeeping genes (seven in the case of the
E. faecium and E. faecalis MLST schemes) (Homan et al., 2002;
Ruiz-Garbajosa et al., 2006). Compared to AFLP, MLST has the
distinct advantage that data are easily collated and shared through
an on-line database. The first analyses of E. faecium MLST data
were performed with the algorithm eBurst (Feil et al., 2004)
and confirmed a distinct clustering of strains derived from the
hospital environment. This cluster was named clonal complex 17
(CC17) and soon CC17 was found to be disseminated throughout
the world (Willems et al., 2005; Top et al., 2008). The later use
of larger datasets and different algorithms for the analysis of
MLST data (Didelot and Falush, 2007; Francisco et al., 2009),
showed that eBurst can sometimes fail to correctly assign STs
to clonal complexes (CCs), particularly when genetic variation
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in populations is largely driven by recombination rather than
mutations, like is the case in E. faecium and E. faecalis (Turner
et al., 2007).
Bayesian analysis of population structure (BAPS) has
successfully been used to probabilistically infer the population
structure and levels of recombination of several microbial
pathogens (Corander et al., 2012; Thomas et al., 2014).
When applied to E. faecium MLST data, BAPS allowed the
partitioning of 519 STs of 1720 E. faecium isolates into 13
non-overlapping groups. Of these groups, BAPS 3–3 was
significantly associated with isolates from hospitalized patients,
while BAPS 2–1 and 2–4 were significantly associated with
farm animals. This observation again confirmed that there
exists structure in the E. faecium population, with a distinct
subpopulation of isolates that are almost exclusively found in
hospitalized patients (Willems et al., 2012). One of the important
nodes in the previously described hospital-associated CC17,
ST78, and its descendant STs, grouped in BAPS 2–1 together
with farm animal isolates, while two other important CC17
nodes, ST17 and ST18 with their descendant STs, clustered
in another BAPS group (BAPS 3–3). These findings indicate
that nosocomial E. faecium isolates have not evolved from
a single ancestor, like previously postulated, but rather the
cumulative acquisition of adaptive elements in nosocomial
isolates may have occurred multiple times in different genetic
backgrounds. Another conclusion that could be drawn from
Bayesian modeling of MLST data is that hospital isolates
displayed a relative low-level of admixture, despite the high
recombination rates in E. faecium, suggesting that once strains
have adapted to the distinct hospital niche, they become
ecologically isolated (including isolation by dominance) and
recombination with other populations declines (Willems et al.,
2012).
Despite the overt lack of reproducibility, PFGE long remained
the “gold standard” for molecular typing of E. faecium until
the introduction of whole genome sequence (WGS)-based
epidemiology. Howden et al. (2013) published a landmark
study in which they used whole genome sequencing to track
an outbreak of vanB-VREF in a large hospital in Australia.
Interestingly, detailed phylogenomic analysis and precise
mapping of the vanB gene revealed that 18 of the 36 vanB-
VREF had acquired the vanB transposon during the outbreak
period. This indicates that for vanB-VREF, frequent de novo
generation of VREF through horizontal gene transfer may
contribute to the emergence of VREF, in addition to clonal
spread. This study was followed by multiple other studies that
used whole genome sequencing to investigate the molecular
epidemiology of VREF with high resolution and high accuracy
(Reuter et al., 2013; Salipante et al., 2015; Brodrick et al., 2016;
van Hal et al., 2016). Bender et al. (2016) performed whole
genome sequencing of 49 vanB-VREF, primarily of ST192
(39/49), from invasive infections from hospitals all across
Germany and found that spread of the Tn1549-vanB-type
resistance involved exchange of large chromosomal fragments
between vanB-positive and vanB-negative enterococci rather
than independent acquisition events of the vanB transposon
alone.
WGS-based studies also proposed that the E. faecium
population was divided into two species-level subdivisions, based
on phylogenetic analysis and the determination of average
nucleotide identity (ANI) between the two sub-populations.
The sub-populations were termed clade A or hospital-associated
clade, primarily containing isolates from hospitalized patients
and clade B or community-associated clade, mostly containing
isolates from healthy, non-hospitalized individuals (Galloway-
Peña et al., 2012; Palmer et al., 2012). The high level of
diversity between these two clades indicates that the clade A–
B split is ancient and precedes the modern antibiotic era.
Further work provided further evidence for this split and
showed that the population of E. faecium in clade A had
a second split of more recent date (74 ± 30 years), with
clade A1 containing the majority of clinical isolates and clade
A2 mostly comprising animal-derived strains (Lebreton et al.,
2013). WGS also confirmed that E. faecium was subject to
high rates of recombination, leading to changes in MLST
profile in otherwise closely related strains, which invalidates
the use of MLST for tracking transmission events (van Hal
et al., 2016). Another finding of van Hal et al. (2016) was
that other E. faecium strains are the most important donors
of imported DNA fragments. Specifically, strains from clade
B are an important reservoir for donating foreign DNA
to clade A strains (de Been et al., 2013). These findings
indicate that hospital-acquired clade A1 E. faecium strains have
recently emerged from a background of human commensal
and animal isolates. Tree-like network representations of
E. faecium genomic relatedness based on cgMLST data
also revealed the distinct clustering of human commensal,
animal and human clinical strains (Figure 1). Notably,
in this analysis the animal isolates do not group in a
single clade A2 but form multiple distinct clusters that
are located in the network, between the human commensal
and clinical isolates, indicating that clade A2 may not be
monophyletic, as previously postulated (Lebreton et al., 2013).
Interestingly, clade A1 E. faecium strains have lower fitness in
natural environments, where they are out-competed by other
E. faecium clones (Leclercq et al., 2013). Similarly, clade B
strains outcompete clade A strains in an animal model of
gut colonization in the absence of selection by antibiotics
(Montealegre et al., 2015). These data highlight the exquisite
niche specialization to the hospital environment of clade A1
strains, which may come at a fitness cost in non-hospital
environments.
The WGS-based epidemiological studies described above
generated phylogenetic trees based on SNPs, by mapping
sequencing reads to a reference genome. This approach, although
providing high-resolution typing data, complicates comparisons
of data between studies and hampers the construction of
globally accessible databases. This limitation may be overcome
by using a genome-wide gene-by-gene comparison approach,
as in classical MLST, but with an important extension of
the number of analyzed genes from seven to the entire core
genome of the species, i.e., 1423 genes as in the recently
published core genome MLST (cgMLST) scheme of E. faecium
(de Been et al., 2015). The E. faecium cgMLST scheme
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FIGURE 1 | NeighborNet phylogenetic network to visualize the relationships between 196 E. faecium isolates. The distance matrix underlying the network
was built from all pairwise allelic profile comparisons of 1423 loci of the published E. faecium cgMLST scheme (de Been et al., 2015). Allelic profiles were extracted
from SeqSphere. Small colored circles indicate the origin of isolates. E. faecium clades (A1 and B) inferred from the STs and based on Lebreton et al. (2013) are
indicated by large dotted circles. Notably, in this analysis clade A2 isolates do not group in a single clade but form at least four distinct clusters that are located in the
network and are indicated clade A2_1, A2_2, A2_3 and A2_4.
allowed high-resolution tracing of E. faecium outbreaks and
performed equally well as an SNP-based phylogenetic approach,
but has the advantage that data can be collated in an online
database and a standardized nomenclature for clones can be
used.
E. faecalis
Enterococcus faecalis appears to be the most widespread and
abundant species of Enterococcus and can be found in the
intestines of humans, farm, companion, and wild animals and
in the environment (Mundt, 1963a,b; Devriese et al., 1992a,b;
Tannock and Cook, 2002; Ruiz-Garbajosa et al., 2009). Initial
molecular epidemiological studies, using MLST, showed the
existence of CCs, in which isolates originating from different
hosts are contained (Ruiz-Garbajosa et al., 2006; McBride
et al., 2007). While many E. faecalis clones are shared between
hospitalized patients and other reservoirs, some CCs (specifically
CC2, CC9, and CC87) and STs (ST6 and ST16) seemed to
be enriched among isolates from hospitalized patients (Ruiz-
Garbajosa et al., 2006; McBride et al., 2007; Freitas et al., 2009;
Kuch et al., 2012). Similarly, in isolates collected from across
the globe, antibiotic resistance is more prevalent in strains that
belong to CC2, CC8, CC9, CC16, and CC87 (Kawalec et al.,
2007; McBride et al., 2007; Freitas et al., 2009; Kuch et al.,
2012).
Analysis of the extent of congruence between the topologies
of the seven different MLST gene trees revealed that that all
42 pairwise comparisons of the sequences of the MLST loci
were incongruent. This observation suggests that E. faecalis
is a highly recombinogenic species (Ruiz-Garbajosa et al.,
2006). For this reason Tedim et al. (2015) used BAPS to
investigate the E. faecalis population structure based on MLST
data of hospitalized (n = 133) and non-hospitalized individuals
(n = 173) isolated from feces. A hierarchical BAPS clustering
analysis partitioned the E. faecalis population into 5 BAPS
groups. Contrary to what has been described in E. faecium
and to eBURST based analyses of E. faecalis MLST data,
no significant association was found between isolates from
hospitalized patients and particular E. faecalis BAPS groups
(Tedim et al., 2015).
The first comprehensive E. faecalis phylogenomic study
involved 18 E. faecalis genomes representing clinical (n = 10),
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human commensal (n = 3), and animal isolates (n = 3),
and isolates of unknown origin (n = 2) (Palmer et al.,
2012). The analysis revealed that the phylogenetic diversity of
E. faecalis was limited compared to E. faecium, with variations
in the ANI in a narrow range between 97.8 and 99.5%.
There was also no clear structure in the phylogenetic core
gene tree, with no distinct clustering of isolates according to
source. Similarly, clustering of these 18 isolates supplemented
with 3 other published E. faecalis genomes from a clinical
site, human feces and pig based on an ad hoc developed
E. faecalis cgMLST scheme using tree-like network methods
also revealed no distinct clustering of isolates according to
their source (Figure 2). A recent genome-based study of 515
E. faecalis genomes, mainly isolated from clinical settings on
the British Isles, revealed three dominant lineages of hospital-
associated lineages (L1, L2, and L3). Isolates in L1 and L3
originated from both the UK and USA (Raven et al., 2016).
These data clearly indicate independent clonal expansion with
subsequent national dissemination. The data may also point
toward the existence of specific hospital-associated or hospital-
adapted lineages. However, in order to unequivocally infer
hospital-adapted lineages it is essential to correct the data
for clonal outbreaks, by including outbreak clones only once
in the analysis. The fact that only a limited number of STs
(3, 2, and 2 STs in lineage 1, 2, and 3, respectively) were
represented in these three lineages may suggest that these lineages
contain multiple replicates of outbreaks clones. Analyses for
recombination frequencies in the core genome of L1, L2 and
L3 isolates indicated low levels of recombination, which seems
to contrast with previous MLST-based analyses (Ruiz-Garbajosa
et al., 2006; Raven et al., 2016). Possibly, recombination drove
the initial diversification of E. faecalis but contributed less to
the relatively recent evolution of the three dominant E. faecalis
lineages described by Raven and co-workers (Raven et al.,
2016).
ADAPTIVE ELEMENTS IN NOSOCOMIAL
LINEAGES
Enterococci are ubiquitous in nature, where they act as
commensals and opportunistic pathogens. A consequence of
these different lifestyles is that enterococci need to adapt to
different micro-environments, each one exerting strong selective
pressures. A strategy for bacterial species to survive when
confronted with a wide range of selective pressures is to specialize
in particular fitness peaks. E. faecium probably followed such
an evolutionary trajectory, resulting in the emergence of specific
hospital-adapted lineages. Successful hospital-adapted clones in
E. faecium have the ability to exchange mobile genetic elements,
carrying antimicrobial resistance, and virulence determinants,
by horizontal gene transfer (Leavis et al., 2003; Hegstad et al.,
2010; Palmer et al., 2010; van Schaik et al., 2010). The cumulative
acquisition of adaptive elements has been named “genetic
capitalism”, in which the acquisition of a particular adaptive
element by a particular clone enhances its fitness, thereby
increasing the likelihood of acquiring a second adaptive element
which finally can lead to the emergence of high-risk multidrug-
resistant clones (Baquero, 2004). This cumulative acquisition of
adaptive elements by the hospital-associated E. faecium clade A1
strains is reflected by their larger genome sizes (2,843 ± 159
genes; 2.98 ± 0.15 Mbp), compared to the genomes of strains
in clade A2 (2,597 ± 153 genes; 2.75 ± 0.14 Mbp) or clade
B (2,718 ± 120 genes; 2.84 ± 0.1 Mbp) (Lebreton et al.,
2013).
The first adaptive element that was described as being specific
for hospital-associated E. faecium strains was Esp (Willems et al.,
2001), a surface protein with a signal sequence for transport and a
LPxTG-like motif for cell wall anchoring. The E. faecium esp gene
is located on an integrative conjugative element, called ICEEfm1,
and contributes to biofilm formation, and UTIs and endocarditis
in animal models (Leavis et al., 2004; Heikens et al., 2007, 2011;
Leendertse et al., 2009; Sava et al., 2010; van Schaik et al., 2010;
Top et al., 2011).
In addition to Esp, other determinants were found to be
specific or significantly enriched among hospital-associated
isolates. Characteristics of these genes have been previously
discussed (Leavis et al., 2003; Heikens et al., 2008; Hendrickx
et al., 2009, 2013; Zhang et al., 2013; Paganelli et al., 2016).
Comparative genomic analyses of 73 E. faecium strains revealed
major differences in gene content between clinical (clade A1),
animal (clade A2) and non-clinical (clade B) strains, particularly
through gain and loss of gene clusters with predicted roles
in carbohydrate metabolism (Kim and Marco, 2013; Lebreton
et al., 2013). Many of the clade B-specific genes have a predicted
role in the utilization of complex carbohydrates from dietary
sources, which were replaced with genes that were associated
with the utilization of amino sugars (e.g., galactosamine), which
occur on epithelial cell surfaces and in mucin. This metabolic
switch may have contributed to the niche specialization of
E. faecium.
As mentioned above the population structure of E. faecalis
seems to be significantly different from E. faecium as no clearly
defined E. faecalis ecotypes appear to exist. Correspondingly,
previous studies have reported shared antibiotic resistance and
virulence genes, such as the E. faecalis pathogenicity island,
esp, capsule polysaccharide genes, and genes encoding for
gelatinase, aggregation substance, cytolysin, and Ace, among
E. faecalis isolates from a wide variety of different niches
like the hospital, animals, food products and the environment
(Eaton and Gasson, 2001; Creti et al., 2004; McBride et al.,
2007; Freitas et al., 2009; Solheim et al., 2009; La Rosa
et al., 2015). Note that the absence of clearly defined ecotypes
in E. faecalis can be interpreted as a high multiplicity of
closely related fine-grained ecotypes, none of them reaching
predominance.
Comparative genomic analysis of 18 E. faecalis genomes
showed that the accretion of mobile genetic elements in multiple
E. faecalis lineages appears to be a major source of genome
diversity (Palmer et al., 2012). Although antibiotic resistance and
pathogenicity island traits have converged in some E. faecalis
lineages, substantial differences in gene content exist, indicating
that specialization toward specific ecotypes is not apparent in
this species, in contrast to E. faecium. In addition, a hierarchical
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FIGURE 2 | NeighborNet phylogenetic network to visualize the relationships between 21 E. faecalis isolates. The distance matrix underlying the network
was built from all pairwise allelic profile comparisons of 1298 loci of an ad hoc E. faecalis cgMLST scheme using SeqSphere (http://www.ridom.de/seqsphere/).
Small colored circles indicate the origin of isolates.
clustering based on genome content of 38 E. faecalis genomes
from diverse sources including clinical and non-clinical isolates,
unearthed no evidence of distinct lineages in E. faecalis and no
genes were found to be significantly enriched among clinical
or non-clinical strains (Kim and Marco, 2013). A pangenome
analysis of 168 E. faecalis isolates revealed no genes, or even
homoplastic non-synonymous single nucleotide polymorphisms,
that were ubiquitous in the three dominant lineages of hospital
isolates, while being absent from all other sporadic lineages
(Raven et al., 2016). These observations are all in accordance
with high levels of genetic exchange between ecologically diverse
E. faecalis clones.
In bacteria, mechanisms that preclude the acquisition of
foreign DNA, include the Clustered Regularly Interspaced
Short Palindromic Repeats (CRISPR)-Cas system (Horvath
and Barrangou, 2010) and restriction and anti-restriction
modification (RM-, antiRM-) systems (Clewell et al., 2014).
E. faecalis strains lacking CRISPR-Cas appear to more
readily acquire DNA through horizontal gene transfer and,
consequently have a larger genome size than E. faecalis
strains that carry CRISPR-Cas (Palmer et al., 2010, 2012).
This indicates that the CRISPR-Cas status of E. faecalis
strains may contribute to ecological adaptation. In E. faecium
CRISPR-Cas is only found in a subset of clade B strains, again
highlighting the general lack of barriers to horizontal gene
exchange in this species (Lebreton et al., 2013). Restriction
and anti-restriction systems located on mobile elements
or enterococcal chromosomes can also determine the flow
of adaptive traits among populations of the same and/or
different species (Clewell et al., 2014). Anti-RM systems
include analogs of ArdA (alleviation of restriction of DNA)
that are located on conjugative transposons (CTns) that
are found widely spread in enterococci. ArdA proteins
act against Type I restriction systems (detected in Tn916
and CTn6000) and other genes presumptively involved
in methylation (CTn6000) (Clewell et al., 2014). Recently,
a type IIS restriction-modification (R-M) system SfaNI
was described in E. faecalis (Furmanek-Blaszk and Sektas,
2015).
Other strategies seem to have exerted positive as well as
negative selective pressures on E. faecalis clones. E. faecalis
strain V583 uses phage particles to establish and maintain
dominance of its intestinal niche in the presence of closely
related competing strains (Duerkop et al., 2012). Furthermore,
five of the seven prophages in the same strain (phage01,
phage03, phage04, phage05, and phage07) can be excised
from the bacterial chromosome and four of them produced
infective virions that may promote gene dissemination among
isolates and increase pathogenicity (Matos et al., 2013; La
Rosa et al., 2015). Conversely, Gaca and Gilmore recently
demonstrated how the accretion of mobile genetic elements
in E. faecalis V583, renders it unable to co-exist with native
enterococci in healthy human fecal flora (Gaca and Gilmore,
2016).
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CONCLUSION
The ubiquitous nature of enterococci, the flexibility of their
genomes and the widespread use of antibiotics in human and
veterinary medicine, are important factors that drive the current
emergence of E. faecium and E. faecalis as MDR nosocomial
pathogens.
The population structure of E. faecium is characterized by
a deep phylogenetic split that separates human commensal
isolates (clade B) from farm animal and hospital isolates (clade
A). It is tempting to speculate that the deep phylogenetic
split in E. faecium is driven by anthropogenic influences
since strains from farm animals (clade A2) and clinical
isolates (clade A1), share a common feature as they both
originate from environments where mammalian hosts are
in close contact with each other and usage of antibiotics
is high. The evolutionary trajectory of E. faecium, which
has led to a clear clade structure, suggests that E. faecium
is colonizing rugged fitness landscapes, in which characters
of particular clones in clade A and B impose strong fitness
differences. Under these circumstances, gene exchange between
diverging populations is reduced over large genomic regions,
as a collateral effect of strong divergent selection on genes
involved in local adaptation. This mechanism was named
divergence hitchhiking (DH) (Via, 2012). DH facilitates
the divergence of genes linked to genomic regions that
are most involved in local adaptation, and may explain
the evolution of clones in populations with extensive gene
flow. In E. faecium clade A, DH may have contributed
to the fixation of ecologically important genomic traits,
like antibiotic resistance or genes linked to pathogenicity.
Indeed, using a neutral model incorporating microepidemics
and migration, which mimics a situation where ecological
factors may limit transmission between subpopulations,
showed that E. faecium hospital isolates with extensive
genotype relatedness markedly deviated from this neutral
model compared with other common nosocomial bacteria
like Staphylococcus aureus and Staphylococcus epidermidis,
indicating that these hospital isolates represent a subpopulation
adapted to the hospital environment (Numminen et al.,
2016).
The E. faecalis population analyzed in the studies described
above included human commensal, farm animal and clinical
isolates. It is an open question why this anthropogenic
divergence, as observed in E. faecium, is not seen in E. faecalis.
An explanation for this may reside in differences in population
size of both species. Indeed, E. faecalis seems to be more
widespread and abundant in the intestines of cattle, pigs,
dogs, horses and poultry (Devriese et al., 1987, 1991, 1992a,b,
1994). E. faecalis has also been more frequently isolated from
wild mammals, reptiles, birds, insects, and wild plants than
E. faecium (Mundt, 1963a,b; Martin and Mundt, 1972). Finally,
in healthy humans E. faecalis is also more frequently found
than E. faecium (Tannock and Cook, 2002). Moreover, it
seems that E. faecalis clones are maintained longer in the
gut than E. faecium clones (Ruiz-Garbajosa et al., 2009).
The higher population density of E. faecalis relative to
E. faecium, in combination with its broader host-range,
should provide E. faecalis with more opportunities for genetic
exchange and diversification than E. faecium. High population
densities also assure frequent transmission events, favoring
gene flow among strains. This may act as a unifying force
preventing the evolution of distinct clades in E. faecalis.
Using the same neutral model described above for E. faecium,
showed that the population structure of E. faecalis could
be reflective of the evolutionary dynamics of a generalist
organism which regularly experiences a high level of drift
and gene flow between different host species (Numminen
et al., 2016). Different strategies influence interactions of
E. faecalis with populations of the same or of different species.
A mechanism of substantial genetic exchange in E. faecalis has
been postulated by Manson and co-workers, who described
conjugative transfer of chromosomal fragments driven by
integration of pheromone responsive conjugative plasmids
carrying IS256 insertions and recombination across IS256 copies
in the genome (Manson et al., 2010). The authors demonstrated
that such an event could include transfer and recombination
of up to 857 kb (∼ 25% of the genome) and show that
essentially every chromosomal location can be transferred by
this mechanism. Other strategies may include phages, mobile
genetic elements and the generation of polymicrobial biofilms
(Weigel et al., 2007; La Rosa et al., 2015, 2016; Gaca and Gilmore,
2016).
High-level genetic connectivity of strains between different
niches and hosts might favor dissemination of adaptive elements
(e.g., virulence and resistance genes) that are acquired by
E. faecalis populations in one niche (e.g., animals raised for
food production) and finally end up being selected for in
another environment (e.g., the hospital). In fact, the panmictic
structure of E. faecalis favors its behavior as a collective
evolutionary individual, which has promoted the generalist
lifestyle of E. faecalis. The high level of genetic connectivity
of E. faecalis strains in different niches, in combination with
a relative small genome size, is in accordance with the ‘Black
Queen Hypothesis’. According to this hypothesis collective genes
shared in a highly recombinogenic structure act as “common
goods”, and may favor the loss of genes in a particular niche
in individual strains, provided they are not lost entirely from
the community (Morris et al., 2012). While there is evidence
in favor of this hypothesis, there is still a distinct lack of
studies using WGS to describe the evolution, genetic diversity
and population structure of E. faecalis and these are urgently
needed to validate or falsify the current view of E. faecalis as a
generalist.
In conclusion, E. faecium and E. faecalis are widely distributed
among humans, animals and the environment. The social
behavior of enterococci, which includes the accretion of plasmids,
phages and CTns (Werner et al., 2013; Clewell et al., 2014),
but also the ability to maintain microbial communities (Barnes
et al., 2012; Paganelli et al., 2013), has allowed them to rapidly
acquire antibiotic resistance genes and genetic elements that
increase their ability to colonize and infect patients. E. faecium
and E. faecalis differ in their population structure. E. faecium
has clearly defined sub-populations, one of which contains
Frontiers in Microbiology | www.frontiersin.org 9 May 2016 | Volume 7 | Article 788
fmicb-07-00788 May 24, 2016 Time: 12:30 # 10
Guzman Prieto et al. High-risk Enterococcal Clones
the majority of strains that are currently causing nosocomial
infections. In contrast, E. faecalis is a generalist, with
a highly panmictic population where genes involved in
patient colonization or virulence are widely spread across
niches.
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